GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Advanced Enzyme Technologies Ltd (BOM:540025) » Definitions » Net Cash per Share

Advanced Enzyme Technologies (BOM:540025) Net Cash per Share : ₹0.00 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Advanced Enzyme Technologies Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Advanced Enzyme Technologies's Net Cash per Share for the quarter that ended in Dec. 2023 was ₹0.00.

The historical rank and industry rank for Advanced Enzyme Technologies's Net Cash per Share or its related term are showing as below:

BOM:540025' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 9.17   Med: 24.21   Max: 676.3
Current: 16

During the past 13 years, the highest Price-to-Net-Cash Ratio of Advanced Enzyme Technologies was 676.30. The lowest was 9.17. And the median was 24.21.

BOM:540025's Price-to-Net-Cash is ranked worse than
64.05% of 331 companies
in the Chemicals industry
Industry Median: 8.35 vs BOM:540025: 16.00

Advanced Enzyme Technologies Net Cash per Share Historical Data

The historical data trend for Advanced Enzyme Technologies's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Enzyme Technologies Net Cash per Share Chart

Advanced Enzyme Technologies Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 6.15 12.26 17.42 25.29

Advanced Enzyme Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 25.29 - 24.66 -

Competitive Comparison of Advanced Enzyme Technologies's Net Cash per Share

For the Specialty Chemicals subindustry, Advanced Enzyme Technologies's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Enzyme Technologies's Price-to-Net-Cash Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Advanced Enzyme Technologies's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Advanced Enzyme Technologies's Price-to-Net-Cash falls into.



Advanced Enzyme Technologies Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Advanced Enzyme Technologies's Net Cash per Share for the fiscal year that ended in Mar. 2023 is calculated as

Net Cash per Share (A: Mar. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(4695.99-1376.76-491.02)/111.824
=25.29

Advanced Enzyme Technologies's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Advanced Enzyme Technologies  (BOM:540025) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Advanced Enzyme Technologies Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Advanced Enzyme Technologies's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Enzyme Technologies (BOM:540025) Business Description

Traded in Other Exchanges
Address
Near LIC Service Road, Sun Magnetica, A Wing, 5th Floor, Louiswadi, Thane (West), Thane, MH, IND, 400604
Advanced Enzyme Technologies Ltd is an Indian company engaged in research activities to manufacture and sell enzymes. The Company operates only in one business segment viz. manufacturing and sales of enzymes. The company offers enzymes for human healthcare and nutrition, animal nutrition, food processing, and non-food processing. Some of the products offered by the company are serratiopeptidase, fungal lipase, papain, hemicellulose, and digegrain, among others. Geographically, the entity operates in India, Europe, the USA, Asia, and other countries, of which a majority of the revenue is derived from India.

Advanced Enzyme Technologies (BOM:540025) Headlines

No Headlines